Stereotaxis, Inc. STXS

STXS Company Overview

Stereotaxis, Inc. is a U.S.-based medical technology company focused on robotic systems for minimally invasive endovascular procedures, primarily in the field of cardiac electrophysiology. The company develops robotic magnetic navigation and interventional technologies designed to improve precision, stability, and physician control during catheter-based procedures. Stereotaxis operates within the broader medical devices, robotic surgery, and electrophysiology industries, with its revenue primarily generated through capital equipment sales, recurring disposables and service contracts, and technology licensing arrangements.

The company’s principal platforms include the Genesis Robotic Magnetic Navigation System, robotic drive technologies, navigation software, and related procedural devices used in catheter ablation and interventional procedures. Stereotaxis serves hospitals, academic medical centers, and electrophysiology laboratories globally, particularly institutions performing complex arrhythmia treatments. The company’s strategic positioning is centered on robotic precision, reduced physician radiation exposure, and improved catheter stability compared with conventional manual navigation systems. Founded in 1990 and headquartered in St. Louis, Missouri, Stereotaxis evolved from magnetic guidance research into a specialized robotic healthcare technology provider focused on endovascular robotics and minimally invasive navigation systems.